Quality of life improvement in HIV-1 patients treated with raltegravir in a real-life observational study: RACING. [electronic resource]
- HIV clinical trials 01 2017
- 1-16 p. digital
Publication Type: Journal Article; Observational Study
1945-5771
10.1080/15284336.2016.1251030 doi
Adolescent Adult Anti-HIV Agents--adverse effects Fatigue--diagnosis Female HIV Infections--drug therapy HIV-1--genetics Humans Male Middle Aged Quality of Life Raltegravir Potassium--adverse effects Risk Factors Socioeconomic Factors Surveys and Questionnaires Time Factors Treatment Outcome Young Adult